StockData
BioLineRx Ltd. logo

BioLineRx Ltd. (BLRX) stock

BLRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 3/30
$1.12−0.03 (-2.61%)

Close on Nov 17, 2026Market cap $4.87MP/E –Yield –

BioLineRx gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2025 it was 80.5%, against 68.0% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202580.5%+12.5
FY2024Dec 31, 202468.0%+44.9
FY2023Dec 31, 202323.1%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202679.9%–
Q2 FY2025Jun 30, 202576.3%–
Q2 FY2024Jun 30, 202483.4%–

More BioLineRx figures

See a number that looks wrong?